FoxP3+ Tregs establish a robust immunosuppressive network by overexpressing checkpoint molecules (CTLA-4, PD-1, LAG-3) and secreting inhibitory cytokines (IL-10, TGF-β, IL-35), thereby creating an immune-privileged niche for tumor survival. The gene discussed is CTLA4; the disease is neoplasm.